Background We aimed to describe pre-existing factors associated with severe disease,
primarily admission to critical care, and death secondary to SARS-CoV-2 infection in …

The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in December 2019 in Wuhan challenges pediatric oncologists in an unexpected way. We …

Background Previous studies have shown that children and adolescents with COVID-19
generally have mild disease. Children and adolescents with cancer, however, can have …

The COVID-19 pandemic has considerably changed health services for children with cancer
worldwide by creating barriers throughout the care continuum. Reports available at this time …

Risk factors for severe SARS-Cov-2 infection course are poorly described in children
following hematopoietic cell transplantation (HCT). In this international study, we analyzed …

Several databases are available to determine the burden of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) …

Background Children with cancer are at risk of critical disease and mortality from COVID-19
infection. In this study, we describe the clinical characteristics of pediatric patients with …

We aimed to study the outcomes of COVID‐19 in paediatric cancer patients. On 26 October
2021, we did a systematic search for relevant articles in seven electronic databases followed …

From 8 December 2021 to 26 January 2023, tixagevimab–cilgavimab (TC) was authorized
for pre-exposure prophylaxis of COVID-19. During this period, we used a multidisciplinary …

Background We aimed to use individual patient data to describe pre-existing factors
associated with severe disease, primarily admission to critical care, and death secondary to …